Tang M, O'Grady S, Crown J, Duffy MJ, et al. MYC as a therapeutic target for the treatment of triple-negative breast cancer: preclinical investigations with the novel MYC inhibitor, MYCi975. Breast Cancer Res Treat 2022 Jul 30. pii: 10.1007/s10549-022-06673.
PMID: 35908121